Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
By D. Chu, Yang Pan, Samuel M. S. Cheng, K. P. Hui, P. Krishnan, Yingzhi Liu, D. Ng, Carrie K C Wan, Peng Yang, Quanyi Wang and 2 more. Clinical Chemistry, 2020
1,217 citations recorded by the source corpus.
Abstract Background A novel coronavirus of zoonotic origin (2019-nCoV) has recently been identified in patients with acute respiratory disease. This virus is genetically similar to SARS coronavirus and bat SARS-like coronaviruses. The outbreak was initially detected in Wuhan, a major city of China, but has subsequently been detected in other provinces of China. Travel-associated cases have also been reported in a few other countries. Outbreaks in health care workers indicate human-to-human transmission. Molecular tests for rapid detection of this virus are urgently needed for early identification of infected patients. Methods We developed two 1-step quantitative real-time reverse-transcription PCR assays to detect two different regions (ORF1b and N) of the viral genome. The primer and probe sets were designed to react with this novel coronavirus and its closely related viruses, such as SARS coronavirus. These assays were evaluated using a panel of positive and negative controls. In addition, respiratory specimens from two 2019-nCoV-infected patients were tested. Results Using RNA extracted from cells infected by SARS coronavirus as a positive control, these assays were shown to have a dynamic range of at least seven orders of magnitude (2x10−4-2000 TCID50/reaction). Using DNA plasmids as positive standards, the detection limits of these assays were found to be below 10 copies per reaction. All negative control samples were negative in the assays. Samples from two 2019-nCoV-infected patients were positive in the tests. Conclusions The established assays can achieve a rapid detection of 2019n-CoV in human samples, thereby allowing early identification of patients.
Subfields: Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/ab43834edf0db25c9e3f97433db812aac9823f65
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro (2020, methodology): “After 48 h incubation at 37 °C, supernatants were collected to quantify viral loads by TCID50 assay or quantitative real-time RT-PCR (TaqManTM Fast Virus 1-Step Master Mix) following the methods described (Chu et al., 2020).”
- False-negative results of initial RT-PCR assays for COVID-19: A systematic review (2020, background): “for the spike, and the Hel gene for the RNA polymerase gene (RdRp/Helicase) [12, 13].”
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures (2020, methodology): “used for detecting viral RNA, and were considered a gold standard.(2,11,34,43) However, this method had its limitations, such as short detection window from nasopharyngeal swabs, false sampling, TABLE 3 Clinical, laboratory, and radiologic characteristics of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2”
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup (2020, neutral): “Nucleic acid−based tests for detection of the virus during acute disease are in use worldwide (Chu et al., 2020; Corman et al., 2020).”
- Coronavirus disease 2019 (COVID-19): current status and future perspectives (2020, neutral): “Thus, the nucleic acid of SARS-CoV-2 can be detected by RT-qPCR or by viral gene sequencing of nasopharyngeal and oropharyngeal swabs, stool, sputum or blood samples [60 , 61] .”
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection (2020, neutral): “SARS-CoV-2 specific primers targeting the N gene region: 5 0 -TAATCAGACAAGGAACTGATTA-3 0 (Forward) and 5 0 - CGAAGGTGTGACTTCCATG-3 0 (Reverse) (Chu et al., 2020) were used with the Luna Universal One-Step RT-qPCR Kit (NEB) in an Applied Biosystems QuantStudio 7 thermocycler, with the following…”
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. (2020, neutral): “Briefly, SARS-CoV-2–specific primers targeting the N gene region: 5′-TAATCAGACAAGGAACTGATTA-3′ (forward) and 5′-CGAAGGTGTGACTTCCATG-3′ (reverse) (57) were used with the Luna Universal One-Step RT-qPCR Kit (New England Biolabs) in an Applied Biosystems QuantStudio 6 thermocycler, with the following c”
- Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets (2020, neutral): “In the United States, we recommend using the US CDC SARS-CoV-2 assay because: (1) we found similar analytical sensitivity as compared to the other three assays; (2) we detected a low rate of inconclusive results with low-virus clinical samples; (3) it includes a human RNase P primer–probe set (RP) t”